These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 9630823
21. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. Backman JT, Mäenpää J, Belle DJ, Wrighton SA, Kivistö KT, Neuvonen PJ. Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247 [Abstract] [Full Text] [Related]
22. In vivo effects of interleukin-10 on human cytochrome P450 activity. Gorski JC, Hall SD, Becker P, Affrime MB, Cutler DL, Haehner-Daniels B. Clin Pharmacol Ther; 2000 Jan; 67(1):32-43. PubMed ID: 10668851 [Abstract] [Full Text] [Related]
23. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. Gorski JC, Vannaprasaht S, Hamman MA, Ambrosius WT, Bruce MA, Haehner-Daniels B, Hall SD. Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371 [Abstract] [Full Text] [Related]
24. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam. Masica AL, Mayo G, Wilkinson GR. Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333 [Abstract] [Full Text] [Related]
25. Simvastatin does not affect CYP3A activity, quantified by the erythromycin breath test and oral midazolam pharmacokinetics, in healthy male subjects. Prueksaritanont T, Vega JM, Rogers JD, Gagliano K, Greenberg HE, Gillen L, Brucker MJ, McLoughlin D, Wong PH, Waldman SA. J Clin Pharmacol; 2000 Nov; 40(11):1274-9. PubMed ID: 11075313 [Abstract] [Full Text] [Related]
26. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone. Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ. Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286 [Abstract] [Full Text] [Related]
27. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics. Liangpunsakul S, Kolwankar D, Pinto A, Gorski JC, Hall SD, Chalasani N. Hepatology; 2005 May; 41(5):1144-50. PubMed ID: 15841467 [Abstract] [Full Text] [Related]
28. Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes. Ito K, Ogihara K, Kanamitsu S, Itoh T. Drug Metab Dispos; 2003 Jul; 31(7):945-54. PubMed ID: 12814973 [Abstract] [Full Text] [Related]
32. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Ma B, Prueksaritanont T, Lin JH. Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508 [Abstract] [Full Text] [Related]
33. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. Damkier P, Hansen LL, Brosen K. Br J Clin Pharmacol; 1999 Dec; 48(6):829-38. PubMed ID: 10594487 [Abstract] [Full Text] [Related]
34. Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Bailey DG, Bend JR, Arnold JM, Tran LT, Spence JD. Clin Pharmacol Ther; 1996 Jul; 60(1):25-33. PubMed ID: 8689808 [Abstract] [Full Text] [Related]
35. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite. Cook CS, Hauswald C, Oppermann JA, Schoenhard GL. J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551 [Abstract] [Full Text] [Related]
40. Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine. Stein CM, Kinirons MT, Pincus T, Wilkinson GR, Wood AJ. Clin Pharmacol Ther; 1996 Jan; 59(1):47-51. PubMed ID: 8549033 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]